Leigh Brody
InvestorInvestor at AlbionVC · Member and Angel Investor at Alma Angels
London
Writes $5M – $10M checks · typically $7M
About
Leigh Brody is an Investment Manager at AlbionVC focused on transformative technologies and therapeutics in life sciences, having joined the firm in 2021. Before that she founded a spin-out based on her own technology and helped build several early-stage life science companies, including Desktop Genetics and Quell Therapeutics. She holds a PhD from Imperial College London and a BSc in Biochemistry from Simmons University.
Contact· self-published, not guessed
Invests in
BiotechDigital Health
Experience
- AlbionVCInvestment Managercurrent2021 — presentGreater London
- Great Ormond Street Hospital CharityBoard Trustee and Member of the Grants and Impact Committeecurrent2026 — present
- Scripta TherapeuticsBoard Observer & Investorcurrent2025 — present
- Various StartupsAngel Investorcurrent2023 — present
- Alma AngelsMember and Angel Investorcurrent2022 — presentLondon, England, United Kingdom
- Bloomsbury Genetic TherapiesBoard Director & Investor2022 — 2026London, England, United Kingdom
- Quell TherapeuticsExecutive Director of Platform Strategy2019 — 2020London, United Kingdom
- Desktop GeneticsChief Scientific Officer2015 — 2019
- GlobalAcorn (Advanced Therapeutics)Founder2012 — 2014London, United Kingdom
- Index VenturesLife Science Investor2013 — 2014London, United Kingdom
- The Broad Institute of Harvard and MITResearch Scientist2005 — 2008Cambridge, Massachusetts
Skills & more
Cell Biology35Molecular Biology31Biochemistry19Cell Culture13Confocal Microscopy10Bioinformatics10qPCR8Genetics8Biotechnology10Genomics7Tissue Culture6Life Sciences10
+12 more
Western BlottingScienceFluorescence MicroscopyScientific WritingIn VivoPCRClinical ResearchLifesciencesRNAiRT-PCRDrug DiscoveryMolecular CloningFrom Leigh's professional profile.
Investments
Investor
CS GeneticsFlokScripta Tx
Per the firm's website.
Colleagues at AlbionVC
Adam Chirkowski
Investor at AlbionVC
Andrew Elder
Deputy Managing Partner at AlbionVC
Cat McDonald
Investor at AlbionVC
Charlotte Lawrence
Managing Director, Direct Equity at British Business Bank
Christina Theilgaard
Head of IR & Institutional Fundraising at Albion Capital Group
Christina Theilgaard
Head of IR & Institutional Fundraising at AlbionVC
Christoph Ruedig
Investor at AlbionVC
Dave Wascha
Operating Partner at AlbionVC
Network2
Investors connected to Leigh in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Leigh Brody?
- Leigh Brody is an Investment Manager at AlbionVC focused on transformative technologies and therapeutics in life sciences, having joined the firm in 2021. Before that she founded a spin-out based on her own technology and helped build several early-stage life science companies, including Desktop Genetics and Quell Therapeutics. She holds a PhD from Imperial College London and a BSc in Biochemistry from Simmons University.
- Where does Leigh Brody work?
- Leigh Brody is Investor at AlbionVC.
- What does Leigh Brody invest in?
- Leigh Brody invests in Biotech, Digital Health.
- What check size does Leigh Brody write?
- Leigh Brody typically writes checks of $5M – $10M.
- What companies has Leigh Brody invested in?
- Investments tracked here include CS Genetics, Flok, Scripta Tx.
- Where did Leigh Brody go to school?
- Leigh Brody studied at Imperial College London (PhD); Simmons University (Bachelor of Science (BSc), Biochemistry).
Same school
Also attended Imperial College London584
Deji SasegbonVP, Platform & Portfolio Operations at EchoVC PartnersMadison LenormandInvestor at DaphniLoubaba El AyoubiInvestor at NorthzoneGiovanni MariggiInvestor at MedicxiFrancois PrinslooInvestor at MedicxiBen PerryInvestor at Medicxi
+ 578 more
Also attended Simmons University9
Zoe AngellInvestor at Third Rock VenturesFelicityInvestment Manager at BoxOne VenturesTheresa PetersonSenior Advisor at Material ImpactKelly LaferriereChief Business Officer at A-Rod CorpKelly O’ConnellManaging Partner at 360 Venture CollectiveFederico LosaPrincipal at Aermont
+ 3 more
Shared employers
Also worked at Great Ormond Street Hospital Charity1
Also worked at Scripta Therapeutics4
Also worked at Quell Therapeutics6
Yogesh KamraHead of Lab Operations (UK site) at Illumina VenturesMichael TedescoAnalyst at Miami University Redhawk VenturesManish GuptaSeed-stage investor in B2B and emerging technologies companies through Merak VenturesFreddie DearPrincipal at Monograph Capital PartnersAnnette ClancyPharma M&A Strategy at Jeito CapitalEstelle RuotteFinance Manager, Fund at Jeito Capital



































